Sudarshan Pharma (SUDARSHAN) | Stock Overview & Key Data
Sudarshan Pharma Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: ₹452.70 on September 30, 2024
Explore how other Indian stocks compare to their 52-week ranges: View IN Market 52-Week Insights
Key Statistics
Join Our India Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Financial Highlights
Quarter Income Flow
Jun 30, 2025
Annual Income Flow
2025
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Sudarshan Pharma
SUDARSHAN
|
7.29B Small-cap | -6.63% | 10.91% | 32.55% | 30.44% | 27.16% | 19.22% | 423.13% | 459.90% | 459.90% | 459.90% | 459.90% |
|
Navin Fluorine
NAVINFLUOR
|
322.36B Large-cap | -2.88% | 3.52% | 15.79% | 20.71% | 18.59% | 67.30% | 54.46% | 123.78% | 1,600.30% | 12,289.64% | 10,949.29% |
|
Deepak Nitrite
DEEPAKNTR
|
230.55B Large-cap | -0.93% | -3.05% | 14.11% | 11.57% | -0.14% | -17.03% | -19.39% | -2.87% | 1,957.49% | 8,856.34% | 9,344.13% |
|
Ghcl
GHCL
|
46.18B Small-cap | -3.53% | -15.40% | -2.81% | -27.72% | -20.48% | -25.88% | -6.75% | 66.32% | 167.15% | 1,049.75% | 177.09% |
|
Styrenix Performance
STYRENIX
|
41.02B Small-cap | -1.65% | -0.61% | 19.11% | 8.02% | 10.05% | -27.51% | 160.17% | 55.99% | 279.89% | 326.65% | 1,649.71% |
|
Chemplast Sanmar
CHEMPLASTS
|
38.60B Small-cap | -6.65% | -9.47% | -7.17% | -26.07% | -18.98% | -49.01% | -51.86% | -60.15% | -60.15% | -60.15% | -60.15% |
Ownership & Short Interest
Calculate Your Sudarshan Pharma Investment Returns
Long-Term Investment Performance Analysis
Sudarshan Pharma stock price in Mar 2023 was ₹6.26, A ₹1,000.00 lump sum investment in Sudarshan Pharma made 3 years ago would be worth approximately ₹5,506.39 today, representing a exceptional return of 450.64%. This translates to an annualized return (CAGR) of 70.17%.
3 Years 2 Months Investment Scenario (Mar 2023 - Jun 2026)
Investment Breakdown
Value Comparison
Disclaimer: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing. Past performance does not guarantee future results.
Frequently Asked Questions
- What is SUDARSHAN's 52-week high and low?
- In the last 52 weeks, Sudarshan Pharma reached a high of ₹36.95 (on May 27, 2026) and a low of ₹18.50 (on January 29, 2026).
- What is the market cap and P/E ratio for SUDARSHAN?
- Curious about Sudarshan Pharma's size and valuation? Its market capitalization stands at 7.29B. When it comes to valuation, the P/E ratio (trailing twelve months) is 35.73, and the forward P/E (looking ahead) is N/A.
- Does SUDARSHAN pay dividends? If so, what's the yield?
- As for dividends, Sudarshan Pharma isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Sudarshan Pharma's main competitors or similar companies to consider before investing?
When looking at Sudarshan Pharma, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Navin Fluorine
NAVINFLUOR322.36B Basic Materials Chemicals 67.30% 54.46% Deepak Nitrite
DEEPAKNTR230.55B Basic Materials Chemicals -17.03% -19.39% Ghcl
GHCL46.18B Basic Materials Chemicals -25.88% -6.75% Styrenix Performance
STYRENIX41.02B Basic Materials Chemicals -27.51% 160.17% Chemplast Sanmar
CHEMPLASTS38.60B Basic Materials Chemicals -49.01% -51.86% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Sudarshan Pharma Industries Ltd.? (e.g., ROE, Debt/Equity)
- To get a sense of Sudarshan Pharma's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 12.13%, the Debt to Equity ratio from the most recent quarter is 155.50, and its Gross Profit Margin stands at 12.03%.
- What is the recent revenue and earnings growth for SUDARSHAN?
- Looking at Sudarshan Pharma's growth, its revenue over the trailing twelve months (TTM) was INR6B. Compared to the same quarter last year (YoY), quarterly revenue grew by 45.30%, and quarterly earnings saw a YoY growth of 51.20%.
- How much of SUDARSHAN stock is held by insiders and institutions?
- Wondering who owns Sudarshan Pharma stock? Company insiders (like executives and directors) hold about 76.52% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 0.00%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.